Ruben Herrendorff

CEO, Co-founder

Ruben is a co-founder and Chief Executive Officer of Polyneuron. His drug discovery expertise, including chemical synthesis, assay development, compound screening, profiling and in vivo pharmacology led him to co-develop the anti-MAG neuropathy drug candidate PN-1007. He is an expert in the underlying core technology Antibody-Catch™. Ruben holds...

Roles at Polyneuron Pharmaceuticals

  • CEO, Co-founder

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.